TOVERA: Ultrasound is a promising biomarker of early treatment response Presented ByDr Maria Stoenoiu, Cliniques Universitaires Saint-Luc, Belgium TrialPhase 3, TOVERA ConferenceEULAR 2021 TypePeer-reviewed article 2 August 2021 21:00